Florida healthcare reform lawsuit: Brace for overreaction (Morning Read)

Among today’s current medical news: Another court decision on healthcare reform; Health IT business model problems with electronic medical records; a new dimension for the artificial pancreas; and FDA approvals for Roche and Novartis.

Current medical news and unique business news for anyone who cares about the healthcare industry.

Florida healthcare decision looms. A ruling in the Florida lawsuit against President Obama’s healthcare reform law, a case that represents more than two dozen states, should be announced today. Legal expert Andrew Cohen predicts everyone will overreact to what he considers a virtual lock that the Florida judge will reject healthcare reform.

The bigger news, he says, is that a recent Supreme Court ruling “confirms to the world that no more than seven votes on the Supreme Court are still in play over the constitutionality of the federal health care measure.”

Electronic health records cash crunch? Electronic medical records vendors are “spending money like crazy” even as providers are slow to adopt and a subscription-based business model requires flush bank accounts some vendors don’t have, says Software Advice CEO Dan Fomes.

FDA approvals. The U.S. Food and Drug Administration has approved Novartis’ Menveo meningitis vaccine for children ages 2 to 10, but the company must reapply to use it in younger children. Also, the FDA approved Roche’s  Rituxan/MabThera as a first-line treatment for particular lymphoma.

Artificial pancreas development. A new study says the “artificial pancreas” can help pregnant women with type 1 diabetes by cutting cases of stillbirth and death.

Meet the stetheadphone. Headphones shaped like a stethoscope.